$4.9M NIH Grants Fuel Feinstein Institutes' Research in Inflammation and Alzheimer’s — The Feinstein Institutes for Medical Research

Event summary

$4.9M in NIH grants awarded to Feinstein Institutes for multi-year research on acute inflammation and Alzheimer’s disease.
Grants support two distinct projects: one led by Drs. Aziz and Wang on B-1a cells in acute inflammation, the other by Drs. Sharma, Wang, and Marambaud on neurotoxic astrocytes in Alzheimer’s.
Research aims to uncover fundamental biological mechanisms for potential therapeutic interventions.

The big picture

The NIH grants underscore the growing focus on understanding fundamental disease mechanisms to drive therapeutic innovation. Feinstein Institutes' work aligns with broader industry trends toward precision medicine and bioelectronic interventions, positioning it as a key player in biomedical research. The $4.9M funding highlights the strategic importance of public-private collaborations in advancing high-impact medical research.

What we're watching

Therapeutic Breakthroughs: Whether the research on B-1a cells and neurotoxic astrocytes will identify actionable therapeutic targets for acute inflammation and Alzheimer’s.
Funding Momentum: The pace at which Feinstein Institutes can secure additional grants or private funding to sustain long-term research initiatives.
Industry Collaboration: How partnerships with healthcare providers like Northwell Health will accelerate the translation of findings into clinical applications.